ADAPTIVE BIOTECHNOLOGIES CORPORATION Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- ADAPTIVE BIOTECHNOLOGIES CORPORATION stock issued during period, value, new issues for the quarter ending 2020-12-31 was $0.00.
- ADAPTIVE BIOTECHNOLOGIES CORPORATION stock issued during period, value, new issues for the quarter ending 2020-09-30 was $271.84M, a 15.28% decline year-over-year.
- ADAPTIVE BIOTECHNOLOGIES CORPORATION stock issued during period, value, new issues for the quarter ending 2019-12-31 was $0.00.
- ADAPTIVE BIOTECHNOLOGIES CORPORATION stock issued during period, value, new issues for the quarter ending 2019-09-30 was $320.85M.
- ADAPTIVE BIOTECHNOLOGIES CORPORATION stock issued during period, value, new issues for fiscal 2020 was $271.84M, a 15.28% decline from fiscal 2019.
- ADAPTIVE BIOTECHNOLOGIES CORPORATION stock issued during period, value, new issues for fiscal 2019 was $320.85M.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-14 | $271.84M 10-K · filed 2023-02-14 |
| 2020-09-30 | $271.84M 10-Q · filed 2021-11-03 | |
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-15 | $320.85M 10-K · filed 2022-02-15 |
| 2019-09-30 | $320.85M 10-Q · filed 2020-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IOVANCE BIOTHERAPEUTICS, INC. (IOVA) | United States | $4.897B | -6.51 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 | |
| Relay Therapeutics, Inc. (RLAY) | United States | $3.884B | -14.30 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Tarsus Pharmaceuticals, Inc. (TARS) | United States | $3.329B | -58.60 |
| Denali Therapeutics Inc. (DNLI) | United States | $3.274B | -8.04 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| Greenland Mines Ltd (GRML) | United States | $2.362B |